NSE: VIJAYA · Healthcare Service Provider
Snapshot
Growth · Profitability · Valuation · Strength · Conviction
Vijaya Diagnostic Centre Limited is a prominent Indian healthcare provider offering a comprehensive range of diagnostic services, including laboratory testing and advanced radiology imaging. The company operates a robust network of diagnostic centres and reference laboratories across multiple states, focusing on clinical pathology, molecular diagnostics, and specialised imaging.
The company generates revenue through the provision of diagnostic services to patients, including laboratory tests, radiology, and imaging procedures. It further monetises its infrastructure through health check-up packages and home sample collection services.
Growth is driven by the expansion of the diagnostic network into new geographies and the increasing demand for specialised diagnostic and imaging services. The company continues to leverage its established brand presence in Telangana, Andhra Pradesh, and other key urban markets.
Unlock AI insights, financials, peers and live data on Vijaya Diagnostic Centre Ltd. and 5,000+ companies — free.
REVENUE
₹857 Cr
TTM · consolidated
NET PROFIT
₹187 Cr
TTM · consolidated
EPS
₹18.23
TTM · consolidated
RETURN ON EQUITY
21.4%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
23.1%
TTM · consolidated
P/E
81.9x
Q1 FY27 · consolidated
EV/EBITDA
39.9x
Q1 FY27 · consolidated
EBITDA MARGIN
44.8%
TTM · consolidated
NET PROFIT MARGIN
23.0%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.0x
Q1 FY27 · consolidated
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Vijaya Diagnostic Centre Ltd.VIJAYA | ₹15,365 Cr | 81.91 | 39.89 | 20.2% | 44.8% | 21.4% | 23.1% | +37.1% |
Metropolis Healthcare Ltd.METROPOLIS | ₹12,205 Cr | 25.21 | 27.32 | 21.8% | 26.0% | 14.3% | 17.8% | -73.7% |
Thyrocare Technologies Ltd.THYROCARE | ₹9,170 Cr | 33.71 | 30.64 | 21.1% | 34.0% | 31.1% | 38.4% | -57.0% |
Nephrocare Health ServicesNEPHROPLUS | ₹6,994 Cr | — | — | — | 23.0% | — | — | — |
Krsnaa Diagnostics Ltd.KRSNAA | ₹1,817 Cr | 18.63 | 8.75 | 10.2% | 32.5% | 10.5% | 13.3% | -32.6% |
Suraksha Diagnostic Ltd.SURAKSHA | ₹1,731 Cr | 47.49 | 16.34 | 22.5% | 32.7% | 15.8% | 18.6% | +9.8% |
As of Q1 FY27
Vijaya Diagnostic Centre Ltd.
NSE: VIJAYA · Healthcare Service Provider
Snapshot
Growth · Profitability · Valuation · Strength · Conviction
Vijaya Diagnostic Centre Limited is a prominent Indian healthcare provider offering a comprehensive range of diagnostic services, including laboratory testing and advanced radiology imaging. The company operates a robust network of diagnostic centres and reference laboratories across multiple states, focusing on clinical pathology, molecular diagnostics, and specialised imaging.
The company generates revenue through the provision of diagnostic services to patients, including laboratory tests, radiology, and imaging procedures. It further monetises its infrastructure through health check-up packages and home sample collection services.
Growth is driven by the expansion of the diagnostic network into new geographies and the increasing demand for specialised diagnostic and imaging services. The company continues to leverage its established brand presence in Telangana, Andhra Pradesh, and other key urban markets.
Unlock AI insights, financials, peers and live data on Vijaya Diagnostic Centre Ltd. and 5,000+ companies — free.
REVENUE
₹857 Cr
TTM · consolidated
NET PROFIT
₹187 Cr
TTM · consolidated
EPS
₹18.23
TTM · consolidated
RETURN ON EQUITY
21.4%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
23.1%
TTM · consolidated
P/E
81.9x
Q1 FY27 · consolidated
EV/EBITDA
39.9x
Q1 FY27 · consolidated
EBITDA MARGIN
44.8%
TTM · consolidated
NET PROFIT MARGIN
23.0%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.0x
Q1 FY27 · consolidated
As of Q1 FY27